Ioxitalamic acid
As of the edition of 20 October 2026, Ioxitalamic acid is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Telebrix
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Guerbet
- Withdrawn from market
- 1 January 1998 (in some regions)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.